Malaria Roadmap Announced

Researchers should aim to develop a vaccine by 2030 that can reduce malaria cases by 75 percent and eventually eliminate the disease, according to a new roadmap launched this week.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

False-colored electron micrograph of a sporozoite migrating through the cytoplasm of midgut epitheliaWIKIMEDIA, IMAGE BY UTE FREVERT; FALSE COLOR BY MARGARET SHEARTo successfully eliminate malaria, which currently causes an estimated 660,000 deaths each year, researchers must develop vaccines that reduce cases by 75 percent, a new roadmap released Thursday (November 14) suggests.

“Safe, effective, affordable vaccines could play a critical role in defeating malaria,” Robert Newman, director of the World Health Organization’s Global Malaria Programme, said in a press release. “Despite all the recent progress countries have made, and despite important innovations in diagnostics, drugs and vector control, the global burden of malaria remains unacceptably high.”

The 2013 Malaria Vaccine Technology Roadmap, launched today at the annual conference of the American Society of Tropical Medicine & Hygiene in Washington, DC, and announced in The Lancet, is an update to a 2006 plan that focused on a Plasmodium falciparum vaccine for children in sub-Saharan Africa by 2015—a goal that very well may be met by GlaxoSmithKline’s RTS,S vaccine candidate, which last month scored high marks for protecting children ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio